AI diagnostics in South Africa face tougher proof and regulatory tests

South Africa’s shift toward AI-assisted diagnostics is moving from pilot projects to routine clinical use, but only technologies that prove clinical value, fit local workflows and clear regulatory hurdles are likely to scale. The issue will be a central topic at World Health Expo 2026 in Johannesburg, where providers, suppliers and regulators will debate how to deploy digital health tools safely and at speed.

Why it matters: - AI-assisted diagnostics are expanding in South African healthcare, but routine adoption will depend on clinical evidence, local validation and regulatory compliance. - Health systems are under pressure to use digital tools to improve earlier detection, workflow efficiency and specialist capacity without increasing risk to patients. - Procurement decisions now need to account for performance in real-world settings, not just results from pilots or vendor demonstrations.

What happened: - South Africa’s healthcare sector is moving toward a more predictive, data-driven model supported by AI diagnostics, interoperable patient records and connected devices. - World Health Expo 2026 will take place at Gallagher Convention Centre in Johannesburg from 6–8 October. - The event returns to Johannesburg after two editions in Cape Town. - WHX will gather healthcare providers, laboratory and diagnostic professionals, technology suppliers, policymakers, investors, distributors and regulatory stakeholders from South Africa, the SADC region and international markets. - The expo will host three specialist Indabas focused on healthcare operations, laboratory innovation and quality and patient safety. - WHX expects more than 10,000 professional visitors, more than 600 exhibitors from 60 countries and 13 country pavilions across 15,000 square metres. - The IT & Solutions sector will showcase digital health, connected care and Internet of Medical Things suppliers.

The details: - AI-enabled diagnostic tools are being used or considered in radiology, pathology and laboratory medicine. - A successful pilot does not prove a product is ready for routine clinical use. - Health organisations need to test systems across representative patient populations and inside the workflows of clinicians who will use them. - Diagnostic review should go beyond reported accuracy and examine false-positive and false-negative rates, consistency across patient groups and facilities, clinician override options, and the effects of algorithm updates or unfamiliar data. - Grand View Research’s Horizon Databook estimates South Africa’s connected healthcare ecosystem at US$47 million in 2025, growing to US$77.4 million by 2033. - The South African Health Products Regulatory Authority has confirmed that AI- and machine-learning-enabled medical devices, including standalone software and software embedded in hardware, fall under South Africa’s medical-device regulatory framework. - Suppliers must choose the correct regulatory pathway and secure authorisation before placing qualifying devices on the market or making them available for use in South Africa. - Procurement due diligence should cover intended use, risk classification, clinical evidence, local relevance, known limitations, data governance, cybersecurity and post-deployment monitoring. - The Healthcare Excellence Indaba will run on 6 October and focus on resilient, future-ready health systems. - The programme will cover hospital infrastructure, global health priorities, ethical governance and digital transformation, including responsible use of data-driven technologies. - The Labs Leadership Indaba, in partnership with the National Health Laboratory Service, will run on 7 October. - The Labs Leadership Indaba will focus on laboratory innovation, diagnostics and the future of laboratory networks. - The Quality Management & Patient Safety Indaba, in partnership with COHSASA, will run on 8 October. - The Quality Management & Patient Safety Indaba will focus on quality, accreditation and patient safety. - COHSASA says the rise of AI-assisted diagnostics and digital health increases the need for clinical governance, quality management and patient safety measures. - WHX said the event is part of a broader portfolio that includes healthcare events in Nairobi, Lagos and Johannesburg. - WHX also sits alongside Africa Health ExCon in Egypt and the Africa CDC’s Conference on Public Health in Africa, creating a connected ecosystem for policy, procurement and commercial activity. - Event information, registration and exhibition details are available through the event homepage, registration page, stand application page and WHX Connections Programme.

Between the lines: - The market opportunity for connected care is growing, but the release makes clear that commercial momentum alone will not be enough to drive adoption. - The biggest shift is from “can it work?” to “can it work safely, locally and at scale?” - That raises the bar for suppliers, which now need evidence, regulatory readiness and integration planning as much as technical capability. - The emphasis on human oversight, accountability and local testing suggests AI in healthcare will be treated as a clinical support tool, not a replacement for professional judgment. - The Johannesburg event also serves as a signal that Africa’s digital health conversation is moving from concept to implementation.

What’s next: - Suppliers will need to show stronger clinical evidence and clearer regulatory pathways before gaining routine use in South African health systems. - Providers are likely to focus more on interoperability, workforce readiness and patient outcomes when evaluating new tools. - WHX 2026 will be a test of how far the market has moved from pilots and demonstrations toward accountable deployment. - Healthcare leaders, distributors, procurement teams and investors are being invited to register, exhibit or explore sponsorship opportunities.